QSA's Week in BioPharma (#21, 2025)
Health Canada authorizes AbCellera’s clinical trial; CCDD clinical drug data set released; $4.8M cannabis seizure at port; CBSA reinforces export controls; U.S. FDA posts postmarketing drug compliance report; U.S. initiates review of global drug pricing practices; Phase 1 clinical trial approval ...
